Invention Grant
- Patent Title: Galacto-rhamnogalacturonate compositions for the treatment of diseases associated with elevated inducible nitric oxide synthase
-
Application No.: US14405280Application Date: 2013-06-06
-
Publication No.: US09763974B2Publication Date: 2017-09-19
- Inventor: Peter G. Traber , Eliezer Zomer , Anatole A. Klyosov
- Applicant: Galectin Therapeutics, Inc.
- Applicant Address: US GA Norcross
- Assignee: Galectin Therapeutics, Inc.
- Current Assignee: Galectin Therapeutics, Inc.
- Current Assignee Address: US GA Norcross
- Agency: Greenberg Traurig, LLP
- International Application: PCT/US2013/044478 WO 20130606
- International Announcement: WO2013/184892 WO 20131212
- Main IPC: C08B37/00
- IPC: C08B37/00 ; C08B37/06 ; A61K31/715 ; A61K31/732 ; A61K31/738 ; A61K45/06 ; A61K31/736
Abstract:
Aspects of the invention provide methods for treatment of a disease associated with elevated iNOS including autoimmune, chronic inflammatory, neurodegenerative, or cardiovascular diseases. In particular, aspects of the invention relate to the use of a therapeutic formulation comprising a galacto-rhamnogalacturonate for the treatment of a disease associated with elevated iNOS including autoimmune, chronic inflammatory, neurodegenerative, or cardiovascular diseases.
Public/Granted literature
Information query
